/

Cutera, Inc.

CUTR US

CUTR USCutera, Inc.

United States Composite

2.35

USD

+0.23

(+10.59%)

-5.59EPS Dil.

-0.42P/E

46.88MMarket Cap

Next Earnings

May 7

Held by Insiders

4.99%

Held by Institutions

91.12%

Short % of Float

37.79%

YTD Yield

-91.49%

3Y Yield

-93.22%

5Y Yield

-89.11%

Capital Structure

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

ST Debt

LT Borrowings

417

418

LT Finance Leases

Preferred Equity and Hybrid Capital

- -

Shares Outstanding

Market Capitalization

467

301

120

Working Capital

FRC

•

in mil. unless spec.

Mar'23

Jun'23

Sep'23

Total Current Assets

418

370

311

Cash, Cash Equivalents & STI

268

223

180

Accounts Receivable, Net

Inventories

Total Current Liabilities

109

103

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

14.15%

13.22%

9.09%

Net Income, GAAP

-385.32%

-910.08%

-4,200.00%

Free Cash Flow

-NaN%

Total Cash Common Dividend

- -

Total Equity

-15.26%

-26.33%

-126.32%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

2021

231

2022

252

2023

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

2021

-0.02

0.43

-0.08

-0.22

0.12

2022

-0.84

-2.53

-0.62

-0.43

-4.39

2023

-1.26

-1.59

-2.22

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

2021

- -

2022

- -

2023

- -

Company Description

CEO: Mr. Taylor C. Harris
Sector: Healthcare
Industry: Medical Devices
Address: 3240 Bayshore Boulevard Brisbane CA United States 94005
IPO Date: Mar 31, 2004
Website: www.cutera.com
Business: Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Company News

Tipranks
a month ago
Hold Rating on Cutera Amid Operational Challenges and Financial Headwinds

Company Description

CEO: Mr. Taylor C. Harris
Sector: Healthcare
Industry: Medical Devices
Address: 3240 Bayshore Boulevard Brisbane CA United States 94005
IPO Date: Mar 31, 2004
Website: www.cutera.com
Business: Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truFlex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; and excel V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all body and skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and enlighten, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides excel HR, a hair removal solution for all skin types; and xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.